Literature DB >> 9421237

Functional characterization of the human biglycan 5'-flanking DNA and binding of the transcription factor c-Krox.

A M Heegaard1, P Gehron Robey, W Vogel, W Just, R L Widom, J Schøller, L W Fisher, M F Young.   

Abstract

The transcriptional regulation of human biglycan expression under normal and pathological conditions was studied. The 5'-flanking regions of the human and mouse genes were isolated and analyzed; the two promoter regions share 81% identity. Both promoters are without a TATA and CAT box and contain multiple Sp1 sites. Human dermal fibroblasts were transiently transfected with progressive deletional human biglycan 5'-flanking DNA-CAT constructs, and a significant variation in activity among the individual constructs was found. A small deletion in several cases caused a more than 2-fold increase or decrease in promoter activity, thereby mapping the target sites for repressors or activators. Human biglycan expression is reduced in females with Ullrich-Turner syndrome (45,X) and increased in individuals with supernumerary sex chromosomes, and it has been speculated that biglycan plays a role in the short stature phenotype of Turner syndrome. Analysis of the transcriptional regulation of biglycan in individuals with sex chromosome anomalies showed that a -262 to -218 region of the biglycan promoter was differentially regulated. This region was extensively analyzed by DNAse footprinting and electrophoretic mobility shift assays, and a putative binding site for the transcription factor c-Krox was discovered. The binding of c-Krox to a site located at approximately -248 to -230 in the human biglycan promoter was confirmed by using extracts from COS cells expressing recombinant human c-Krox. The expression of c-Krox in bone was then examined by reverse-transcribed polymerase chain reaction and Northern blotting analysis; an approximately 3.4 kb transcript was detected in primary osteoblastic cells, in MG-63 cells, and in human bone marrow stromal cells. This is the first detection of c-Krox in bone cells, and it suggests that c-Krox, like another member of the Krox family, Krox-20, might play a regulatory role in bone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421237     DOI: 10.1359/jbmr.1997.12.12.2050

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  3 in total

1.  Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.

Authors:  P Laine; N Reunanen; L Ravanti; M Foschi; M Santra; R V Iozzo; V M Kähäri
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Biglycan knockout mice: new models for musculoskeletal diseases.

Authors:  Marian F Young; Yanming Bi; Laurent Ameye; Xiao-Dong Chen
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

3.  Characterization of the human proline/arginine-rich end leucine-rich repeat protein (PRELP) gene promoter and identification of a repressor element.

Authors:  J Grover; P J Roughley
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.